Treace Medical Concepts (TMCI) Capital Expenditures (2020 - 2026)

Treace Medical Concepts has reported Capital Expenditures for 7 years, with the latest figure at $3.1 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures fell 13.58% year-over-year to $3.1 million; the trailing twelve-month figure through Mar 2026 stood at $13.0 million (up 16.3% YoY), and the FY2025 full-year result was $13.5 million, up 16.6% from the prior year.
• Capital Expenditures for Q1 2026 stood at $3.1 million, up from $2.4 million in the prior quarter.
• The five-year high for Capital Expenditures was $5.9 million in Q3 2022, with the low at $1.5 million in Q1 2023.
• Historically, Capital Expenditures has averaged $3.2 million across 5 years, with a median of $3.1 million in 2026.
• Annual changes were most pronounced in 2022 — Capital Expenditures surged 671.34% — and 2024, when it tumbled 59.13%.
• Treace Medical Concepts' Capital Expenditures stood at $2.3 million in 2022, then declined by 3.6% to $2.2 million in 2023, then surged by 36.74% to $3.1 million in 2024, then fell by 21.99% to $2.4 million in 2025, then advanced by 27.69% to $3.1 million in 2026.
• The last three Capital Expenditures figures came in at $3.1 million (Q1 2026), $2.4 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.